BioCentury
ARTICLE | Company News

Clavis, Aqualis Offshore deal

September 16, 2013 7:00 AM UTC

Clavis signed a letter of intent to acquire engineering and marine consultancy firm Aqualis in a NOK70 million ($11.5 million) stock deal. Clavis said the deal represents a change in strategic direction, but its existing pharmaceutical activities will remain as a separate business area within the company. The deal is subject to due diligence, the signing of a definitive share purchase agreement and shareholder approval at an October meeting. Carnegie A/S is Clavis' advisor. ...